Pilot Study of Rituximab for Membranoproliferative Glomerulonephritis

Clinical trial NCT00275613 · COMPLETED

Trial details

NCT number: NCT00275613
Sponsor: Mayo Clinic
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Glomerulonephritis, Membranoproliferative

Start date: 2005-11-01
Primary completion: 2009-03-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.